CVS Group plc (LON:CVSG)
London · Delayed Price · Currency is GBP · Price in GBX 1,306.00
-8.00 (-0.61%)
At close: Jan 30, 2026
CVS Group Market Cap
CVS Group has a market cap or net worth of 916.24 million as of January 30, 2026. Its market cap has increased by 38.67% in one year.
Market Cap
916.24M
Enterprise Value
1.15B
Revenue
673.20M
Ranking
n/a
PE Ratio
49.85
Stock Price
1,306.00
Market Cap Chart
Since October 10, 2007, CVS Group's market cap has increased from 4.71M to 916.24M, an increase of 19,341.02%. That is a compound annual growth rate of 33.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 916.24M | 0.91% |
| Dec 31, 2025 | 907.93M | 50.66% |
| Dec 31, 2024 | 602.62M | -49.95% |
| Dec 29, 2023 | 1.20B | -12.67% |
| Dec 30, 2022 | 1.38B | -13.16% |
| Dec 31, 2021 | 1.59B | 49.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.75B |
| GSK plc | 74.30B |
| Haleon | 33.10B |
| Smith & Nephew | 10.31B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.53B |
| Oxford Biomedica | 1.03B |
| Spire Healthcare Group | 824.86M |